Foushee, Casten, Balint, Budzinski, Tokuda Urge HHS and FDA to Ensure Patient Access to Methotrexate and Misoprostol

Nov 14, 2023

WASHINGTON, DC (November 14, 2023) – Today, U.S. Representatives Valerie Foushee (NC-04), Sean Casten (IL-06), Becca Balint (VT-AL), Nikki Budzinski (IL-13), and Jill Tokuda (HI-02) led 48 of their colleagues in a letter to the U.S. Department of Health and Human Services, the HHS Office of Civil Rights, and the Federal Food and Drug Administration urging them to ensure access to methotrexate and misoprostol and urging the restoration of care for people across the country.

“Since the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision in June 2022, people across the country have been denied access to methotrexate and misoprostol,” the lawmakers wrote. “In many states, physicians, other types of providers, and pharmacists must comply with extreme and often confusing abortion bans and restrictions. These laws have created a chilling effect in which providers are fearful to offer medications like methotrexate and misoprostol to manage chronic conditions or for miscarriage management, because they could under another use be used for or cause an abortion. While we appreciate the statement on July 13, 2022, from the Department of Health and Human Services reminding retail pharmacies of their obligation to supply prescribed medications in a nondiscriminatory manner, this issue persists.”

Methotrexate is critical for patients to treat rheumatoid arthritis (RA), other autoimmune disorders, and some cancers, including breast cancer, lymphoma and leukemia, among other conditions. Misoprostol is used to prevent gastric ulcers and helps with managing miscarriages.

The full text of the letter can be found here.

Recent Posts

Jun 13, 2024

Ranking Member Foushee Opening Remarks for SST Investigations & Oversight Hearing on California’s CARB Rule

WASHINGTON, DC (June 13, 2024) — Today, Congresswoman Valerie Foushee (NC-04), Ranking Member of the House Committee on Science, Space, and Technology’s Investigations and Oversight Subcommittee, delivered the following opening remarks at the Subcommittee Hearing titled, Environmentalism Off the Rails: How CARB will Cripple the National Rail Network. You can watch the hearing here. Ranking […]

Jun 3, 2024

Rep. Foushee Introduces Resolution Designating June as Brain and Spine Metastasis Awareness Month

WASHINGTON, DC (June 3, 2024) — Today, Congresswoman Valerie Foushee (NC-04) introduced a resolution designating the month of June as Brain and Spine Metastasis Awareness Month to recognize and reaffirm the commitment to increasing awareness of treatment options for people with cancer that has spread to the brain or spine. “Despite advancements in cancer treatments […]

Apr 26, 2024

Congresswoman Foushee Announces FY25 Community Project Funding Application Process for 4th District

DURHAM, NC (April 26, 2024) — Congresswoman Valerie Foushee (NC-04), announced that her office is accepting applications for Community Project Funding requests from Fourth Congressional district non-profit and governmental entities for Fiscal Year 2025. The deadline for organizations to apply for funding is May 1, 2024 at 12:00PM ET. “Community Project Funding is a critical […]